MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Phenotypic Heterogeneity in PSP Variants – A Case Series

S. BHADRAN, S. ABRAHAM, B. NATARAJAN, A. MEKKATTUKUNNEL, J. KRISHNAN, R. ISAAC, P.K. PAL (THRISSUR, India)

Meeting: 2017 International Congress

Abstract Number: 247

Keywords: Progressive supranuclear palsy(PSP), Rapid eye movement(REM), Tauopathies

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To present the phenotypic heterogeneity we observed in 5 PSP variants.

Background: Progressive supranuclear palsy (PSP) is a primary tauopathy characterised by progressive gait disturbances, postural instability, supranuclear gaze palsy and fronto-limbic cognitive deficits, classical Richardson’s Syndrome. This is the commonest Parkinson plus syndrome constituting 5-6%.1There is considerable phenotypic heterogeneity in the presentation of PSP. Until date 5 variants are well described and newer variants are still evolving. We are presenting our experience of 5 patients with PSP variants.

Methods: Between 2015 and 2016, we encountered 5 patients with PSP, all of which were atypical. All of them met the probable PSP criteria of NINDS-PSPS. However, they varied in their clinical manifestations and had discernible features differing from classic RS-PSP. The clinical characteristics are summarized in table 1.

Results: The PSP-CBS and PSP-P variants we encountered had polysomnographic proven evidence of RBD. This finding is less prevalent in PSP. This would probably be explained from the degeneration of PPTg nuclei in the brain stem, which appears to be vital for the generation of REM sleep.2The median interval between onset and diagnosis is 3 years (range, 0.5-9years). The PSP-PNFA variant presented as early as 4 months. Another peculiarities observed in this patient were rapidly progressing dementia, vertical gaze palsy at symptom onset and substantial reduction in spontaneous speech. The PSP-P variant seems to be the oldest case of PSP reported hitherto, came to the medical limelight when he developed aspiration pneumonia.

Conclusions: The recognition of PSP variants suggests that other than classic Richardson’s  syndrome there are other related, but distinct clinical syndromes, which could be easily misdiagnosed in the early stages. A proper understanding of the variants is crucial in the management considering the rapid progression of this disorder and refractoriness to levodopa therapy.

References:

  1.  David R Williams, Andrew J Lees. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurology 2009; 8: 270-79
  2. Sabra M. Abbott, Aleksander Videnovic. Sleep Disorders in Atypical Parkinsonism. Movement Disorders Clinical practice.

To cite this abstract in AMA style:

S. BHADRAN, S. ABRAHAM, B. NATARAJAN, A. MEKKATTUKUNNEL, J. KRISHNAN, R. ISAAC, P.K. PAL. Phenotypic Heterogeneity in PSP Variants – A Case Series [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/phenotypic-heterogeneity-in-psp-variants-a-case-series/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/phenotypic-heterogeneity-in-psp-variants-a-case-series/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley